• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylethers

Research Brief on 2-(2-Fluorophenoxy)aniline (CAS: 391906-76-6) in Chemical Biology and Pharmaceutical Applications

2-(2-Fluorophenoxy)aniline (CAS: 391906-76-6) is a fluorinated aromatic amine derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and inflammatory pathways. Recent studies have explored its utility in drug discovery, highlighting its role as a building block for novel therapeutic agents.

One of the most promising areas of research involving 2-(2-Fluorophenoxy)aniline is its incorporation into small-molecule inhibitors targeting protein kinases and G-protein-coupled receptors (GPCRs). A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a precursor in the synthesis of selective serotonin reuptake inhibitors (SSRIs) with improved blood-brain barrier permeability. The fluorine substitution at the phenoxy ring enhances the compound's metabolic stability, making it a valuable scaffold for CNS-targeted drugs.

In the field of oncology, researchers have utilized 2-(2-Fluorophenoxy)aniline to develop novel tyrosine kinase inhibitors. A recent patent application (WO2023056789) describes its use in creating compounds with potent activity against EGFR mutations, particularly in non-small cell lung cancer. The fluorophenoxy moiety appears to contribute to enhanced target binding affinity while maintaining favorable pharmacokinetic properties.

The compound's synthetic versatility has also been demonstrated in antimicrobial research. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported its incorporation into novel quinolone derivatives showing activity against drug-resistant Staphylococcus aureus strains. The researchers noted that the 2-fluorophenoxy group significantly improved membrane penetration compared to non-fluorinated analogs.

From a chemical biology perspective, 2-(2-Fluorophenoxy)aniline has shown utility as a fluorescent probe precursor. Its amine group allows for facile conjugation to various fluorophores, creating tools for studying protein-ligand interactions. Recent work published in ACS Chemical Biology described its use in developing FRET-based sensors for real-time monitoring of kinase activity in live cells.

Ongoing research continues to explore the full potential of this compound. Current investigations focus on its application in PROTAC (proteolysis targeting chimera) technology, where it serves as a linker between target-binding and E3 ligase-recruiting moieties. Preliminary results suggest that its balanced hydrophobicity and conformational flexibility make it particularly suitable for this emerging therapeutic modality.

In conclusion, 2-(2-Fluorophenoxy)aniline (391906-76-6) represents a versatile chemical building block with broad applications across multiple therapeutic areas. Its unique physicochemical properties, combined with synthetic accessibility, position it as a valuable tool in modern drug discovery efforts. Future research directions likely include further optimization of its derivatives for improved selectivity and in vivo performance.

• 195136-66-4(3-Fluoro-2,4-dimethoxyaniline)
• 195136-65-3(5-Fluoro-2,4-dimethoxyaniline)
• 305801-12-1(4-(2-Fluorophenoxy)aniline)
• 437-83-2(3-Fluoro-2-methoxyaniline)
• 3169-71-9(2-(4-Fluorophenoxy)aniline)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)